Osteoporosis is a major health problem; however, the mechanisms regulating adult bone mass are poorly understood. Cas-interacting zinc finger protein (CIZ) is a nucleocytoplasmic shuttling protein that localizes at cell adhesion plaques that form where osteoblasts attach to substrate. To investigate the potential role of CIZ in regulating adult bone mass, we examined the bones in CIZ-deficient mice. Bone volume was increased and the rates of bone formation were increased in CIZ-deficient mice, whereas bone resorption was not altered. CIZ deficiency enhanced the levels of mRNA expression of genes encoding proteins related to osteoblastic phenotypes, such as alkaline phosphatase (ALP) as well as osterix mRNA expression in whole long bones. Bone marrow cells obtained from the femora of CIZ-deficient mice revealed higher ALP activity in culture and formed more mineralized nodules than wild-type cells. CIZ deficiency enhanced bone morphogenetic protein (BMP)–induced osteoblastic differentiation in bone marrow cells in cultures, indicating that BMP is the target of CIZ action. CIZ deficiency increased newly formed bone mass after femoral bone marrow ablation in vivo. Finally, BMP-2–induced bone formation on adult mouse calvariae in vivo was enhanced by CIZ deficiency. These results establish that CIZ suppresses the levels of adult bone mass through inhibition of BMP-induced activation of osteoblasts.
Skip Nav Destination
Article navigation
21 March 2005
Article|
March 21 2005
The nucleocytoplasmic shuttling protein CIZ reduces adult bone mass by inhibiting bone morphogenetic protein–induced bone formation
Mikihiko Morinobu,
Mikihiko Morinobu
1Department of Molecular Pharmacology, Tokyo Medical and Dental University
Search for other works by this author on:
Tetsuya Nakamoto,
Tetsuya Nakamoto
4University of Tokyo, Tokyo 113-8655, Japan
Search for other works by this author on:
Kazunori Hino,
Kazunori Hino
1Department of Molecular Pharmacology, Tokyo Medical and Dental University
Search for other works by this author on:
Kunikazu Tsuji,
Kunikazu Tsuji
1Department of Molecular Pharmacology, Tokyo Medical and Dental University
Search for other works by this author on:
Zhong-Jian Shen,
Zhong-Jian Shen
1Department of Molecular Pharmacology, Tokyo Medical and Dental University
Search for other works by this author on:
Kazuhisa Nakashima,
Kazuhisa Nakashima
1Department of Molecular Pharmacology, Tokyo Medical and Dental University
Search for other works by this author on:
Akira Nifuji,
Akira Nifuji
1Department of Molecular Pharmacology, Tokyo Medical and Dental University
Search for other works by this author on:
Haruyasu Yamamoto,
Haruyasu Yamamoto
5Ehime University, Ehime 791-0295, Japan
Search for other works by this author on:
Hisamaru Hirai,
Hisamaru Hirai
4University of Tokyo, Tokyo 113-8655, Japan
Search for other works by this author on:
Masaki Noda
Masaki Noda
1Department of Molecular Pharmacology, Tokyo Medical and Dental University
2Center of Excellence Program for Frontier Research on Molecular Destruction and Reconstruction of Tooth and Bone, Core to Core Program for Advanced Bone and Joint Science, Japan Society for Promotion of Science, Tokyo 101-0062, Japan
3Integrated Action Initiative, Core to Core Program for Advanced Bone and Joint Science, Japan Society for Promotion of Science, Tokyo 101-0062, Japan
Search for other works by this author on:
Mikihiko Morinobu
1Department of Molecular Pharmacology, Tokyo Medical and Dental University
Tetsuya Nakamoto
4University of Tokyo, Tokyo 113-8655, Japan
Kazunori Hino
1Department of Molecular Pharmacology, Tokyo Medical and Dental University
Kunikazu Tsuji
1Department of Molecular Pharmacology, Tokyo Medical and Dental University
Zhong-Jian Shen
1Department of Molecular Pharmacology, Tokyo Medical and Dental University
Kazuhisa Nakashima
1Department of Molecular Pharmacology, Tokyo Medical and Dental University
Akira Nifuji
1Department of Molecular Pharmacology, Tokyo Medical and Dental University
Haruyasu Yamamoto
5Ehime University, Ehime 791-0295, Japan
Hisamaru Hirai
4University of Tokyo, Tokyo 113-8655, Japan
Masaki Noda
1Department of Molecular Pharmacology, Tokyo Medical and Dental University
2Center of Excellence Program for Frontier Research on Molecular Destruction and Reconstruction of Tooth and Bone, Core to Core Program for Advanced Bone and Joint Science, Japan Society for Promotion of Science, Tokyo 101-0062, Japan
3Integrated Action Initiative, Core to Core Program for Advanced Bone and Joint Science, Japan Society for Promotion of Science, Tokyo 101-0062, Japan
CORRESPONDENCE Masaki Noda: [email protected]
Abbreviations used: ALP, alkaline phosphatase; BMP, bone morphogenetic protein; CIZ, Cas-interacting zinc finger protein; COL, type I collagen; LRP5, low-density lipoprotein receptor-related protein 5; OPN, osteopontin; rh, recombinant human; TRAP, tartrate-resistant acid phosphatase.
Received:
June 03 2004
Accepted:
January 18 2005
Online ISSN: 1540-9538
Print ISSN: 0022-1007
The Rockefeller University Press
2005
J Exp Med (2005) 201 (6): 961–970.
Article history
Received:
June 03 2004
Accepted:
January 18 2005
Connected Content
Citation
Mikihiko Morinobu, Tetsuya Nakamoto, Kazunori Hino, Kunikazu Tsuji, Zhong-Jian Shen, Kazuhisa Nakashima, Akira Nifuji, Haruyasu Yamamoto, Hisamaru Hirai, Masaki Noda; The nucleocytoplasmic shuttling protein CIZ reduces adult bone mass by inhibiting bone morphogenetic protein–induced bone formation . J Exp Med 21 March 2005; 201 (6): 961–970. doi: https://doi.org/10.1084/jem.20041097
Download citation file:
Sign in
Don't already have an account? Register
Client Account
You could not be signed in. Please check your email address / username and password and try again.
Could not validate captcha. Please try again.
Sign in via your Institution
Sign in via your InstitutionEmail alerts
Advertisement